Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia

Journal of Diabetes and its Complications

Volumn 23, Issue 1, 2009, Pages 65-70

  Le Guyader, Alexandre ^a,b   Pacheco, Garrett ^a   Seaver, Norma ^a   Davis Gorman, Grace ^a   Copeland, Jack ^a   McDonagh, Paul F ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Aspirin; Diabetes; Flow cytometry; Hyperglycemia; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; FIBRINOGEN RECEPTOR; GLUCOSE; PADGEM PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CELL STRESS; CONCENTRATION (PARAMETERS); DRUG EFFECT; DRUG EFFICACY; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION;

ADULT; ASPIRIN; BLOOD GLUCOSE; GENE EXPRESSION REGULATION; HUMANS; HYPERGLYCEMIA; P-SELECTIN; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; STRESS, PHYSIOLOGICAL;

EID: 56449118813     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2007.06.003     Document Type: Article

References (21)

1. Antithrombotic Trialists' Collabroation. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. British Medical Journal 324 (2002) 71-86
2. Capes S.E., Hunt D., Malmberg K., and Gerstin Hertzel C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 355 (2000) 773-778
3. Colwell J.A. Aspirin therapy in diabetes. Diabetes Care 20 (1997) 1767-1771
4. Doenst T., Wijeysundera D., Karkouti K., Zechner C., Maganti M., Rao V., and Borger M.A. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. Journal of Thoracic and Cardiovascular Surgery 130 (2005) 1144-1150
5. Frelinger A.L., Furman M.I., Linden M.D., Li Y., Fox M.L., Barnard M.R., and Michelson A.D. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: A 700-patient study of aspirin resistance. Circulation 113 (2006) 2888-2896
6. Golanski J., Chlopicki S., Golanski R., Gresner P., Iwaszkiewicz A., and Watala C. Resistance to aspirin in patients after coronary artery bypass grafting is transient. Impact on the monitoring of aspirin antiplatelet therapy. Therapeutic Drug Monitoring 27 (2005) 484-490
7. Golanski J., Nocun M., Rozalski M., Drygas W., and Watala C. An in vitro model for the detection of reduced platelet sensitivity to acetylsalicylic acid. Blood Coagulation and Fibrinolysis 15 (2004) 187-195
8. Gresner P., Dolnik M., Waczulikova I., Bryszewska M., Sikurova L., and Watala C. Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabetic patients: A role of plasma esterases. Biochimica et Biophysica Acta 1760 (2006) 207-215
9. Keating F.K., Sobel B.E., and Schneider D.J. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. American Journal of Cardiology 92 (2003) 1362-1365
10. Marcus A.J. Eicosanoid interactions between platelets, endothelial cells, and neutrophils. Methods in Enzymology 187 (1990) 585-599
11. McDonagh P.F., Hokama J.Y., Gale S.C., Logan J.J., Davis-Gorman G., Goldman S., and Copeland J.G. Chronic expression of platelet adhesion proteins is associated with severe ischemic heart disease in type 2 diabetic patients. Chronic platelet activation in diabetic patients. Journal of Diabetes and its Complications 17 (2003) 269-278
12. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circulation Research 99 (2006) 1293-1304
13. Patrono C., Coller B., FitzGerald G.A., Hirsh J., and Roth G. Platelet-active drugs: The relationships among dose, effectiveness, and side effects: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 Suppl. (2004) 234S-264S
14. Sacco M., Pellegrini F., Roncaglioni M.C., Avanzini F., Tognoni G., Nicolucci A., and on behalf of the PPP Collaborative Group. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients. Diabetes Care 26 (2003) 3264-3272
15. Tuttle H., Davis-Gorman G., Goldman S., Copeland J., and McDonagh P. Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease. Cardiovascular Diabetology 2 (2003) 12
16. Tuttle H.A., Davis-Gorman G., Goldman S., Copeland J.G., and McDonagh P.F. Proinflammatory cytokines are increased in type 2 diabetic women with cardiovascular disease. Journal of Diabetes and its Complications 18 (2004) 343-351
17. Watala C., Golanski J., Pluta J., Boncler M., Rozalski M., Luzak B., Kropiwnicka A., and Drzewoski J. Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-Its relation to metabolic control. Thrombosis Research 113 (2004) 101-113
18. Watala C., Pluta J., Golanski J., Rozalski M., Czyz M., Trojanowski Z., and Drzewoski J. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin. Journal of Molecular Medicine 83 (2005) 148-158
19. Watala C., Ulicna O., Golanski J., Nocun M., Waczulíková I., Markuszewski L., and Drzewoski J. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: A multiparametric aggregation study. Blood Coagulation and Fibrinolysis 17 (2006) 113-124
20. Winocour P.D. Platelets, vascular disease, and diabetes mellitus. Canadian Journal of Physiology and Pharmacology 72 (1994) 295-303
21. Zimmermann N., Wenk A., Kim U., Kienzle P., Weber A.-A., Gams E., Schrör K., and Hohlfeld T. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 108 (2003) 542-547